Streetbeat News

ELV

Elevance Health Inc.

https://www.elevancehealth.com

Industry

Medical - Healthcare Plans

Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.

Open

430.81

Mkt cap

100B

Volume

2M

High

433.38

P/E Ratio

15.62

52-wk high

567.26

Low

425.12

Div yield

0.02

52-wk low

397.98

Elevance Health's stock is trading higher following the announcement of its Q1 earnings per share (EPS) surpassing expectations and an upward revision of its full-year 2023 (FY23) guidance.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 12:52 pm

Earnings reports for April 18, 2024, include a wide range of companies across various sectors. Notable mentions include Nokia, Taiwan Semiconductor, and Netflix, with expectations of earnings per share at $0.06, $1.31, and $4.50 respectively. Other companies like Alaska Air Gr and Ally Financial are also set to report, indicating a diverse earnings day across technology, finance, and consumer sectors.

Portfolio Pulse from Benzinga Insights

April 18, 2024 | 12:10 pm

Elevance Health has updated its forecast for the fiscal year 2024, revising its adjusted EPS guidance to over $37.20, up from the previous outlook of over $37.10, and surpassing the consensus estimate of $37.15.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 10:05 am

Elevance Health (ELV) reported Q1 2024 adjusted EPS of $10.64, surpassing the $10.53 estimate, marking a 12.47% increase from last year. However, their sales of $42.273B fell short of the $42.626B estimate, a slight 0.90% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

April 18, 2024 | 10:02 am

Healthcare stocks are trading higher following UnitedHealth's report of better-than-expected Q1 earnings, positively impacting related stocks.

Portfolio Pulse from Benzinga Newsdesk

April 16, 2024 | 11:17 am

Elevance Health (NYSE:ELV) has delivered an average annual return of 12.93% over the past 20 years, turning a $1000 investment into $11,267.11 today. With a current market capitalization of $115.83 billion, ELV's performance highlights the impact of compounded returns on investment growth.

Portfolio Pulse from Benzinga Insights

April 12, 2024 | 4:00 pm

Cantor Fitzgerald analyst Sarah James has reiterated an Overweight rating on Elevance Health (NYSE:ELV) and maintained a price target of $580.

Portfolio Pulse from Benzinga Newsdesk

April 10, 2024 | 2:11 pm

Wells Fargo analyst Stephen Baxter has maintained an Overweight rating on Elevance Health (NYSE:ELV) but has lowered the price target from $561 to $557.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 12:33 pm

Elevance Health (NYSE:ELV) received seven somewhat bullish ratings from analysts, with a current average 12-month price target of $565.57, reflecting a 1.08% increase from the previous target. The company, a leading U.S. health insurer and the largest provider of Blue Cross Blue Shield branded coverage, reported a solid revenue growth rate of 6.81% and strong financial metrics including net margin, ROE, and ROA. However, its debt-to-equity ratio is higher than the industry average.

Portfolio Pulse from Benzinga Insights

April 04, 2024 | 6:01 pm

Cantor Fitzgerald analyst Sarah James reiterated an Overweight rating on Elevance Health (NYSE:ELV) and maintained a $580 price target.

Portfolio Pulse from Benzinga Newsdesk

April 04, 2024 | 2:06 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.